Clinical Exome Sequencing (CLIA / CAP)
Clinical Exome Sequencing is a CLIA-validated method to probe protein-coding regions of the genome at high depth and with uniform coverage. Our regulatory service provides whole exome sequencing services in our GCP-compliant, CAP-accredited laboratory, ensuring we meet all the regulatory requirements of your clinical research.
Our CLIA-validated next generation sequencing services ensure sensitive and unbiased detection of genetic variants. These assays enable clinical researchers to answer focused biological questions using genome-scale information, fueling the advancement of precision medicine and biomarker discovery.
GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences also offers clinical whole genome sequencing is available for more comprehensive genomic analysis and RUO whole exome sequencing for your non-clinical needs.
Features & Benefits
FROM SEQUENCING TO DISCOVERY
1. SUBMIT SAMPLES
Submit DNA or blood sample
2. SEQUENCE
Sequencing on the Illumina® NovaSeq™ 6000
3. ANALYZE DATA
Receive raw data files and variant report
Service Levels
| Service Level* | Data & Report (FASTQ, BAM & VCF) |
QA Oversight | Lab Director Signature |
| CLIA Environment | |||
|
CLIA-Validated Service |
Included | Not Available
*All service levels are performed by CLIA-trained personnel in a CLIA-certified lab with CLIA-qualified equipment.
